H-group (homology)
3401.1 Envelope glycoprotein GP1
Ligands and drugs
160
Member domains
88
with ligand contacts (≤ 4 Å)
55.0% of members
92
with DrugDomain annotations
57.5% of members
92
with a DrugBank compound
57.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3401.1 belongs to X-group 3401 Envelope glycoprotein GP1, which has 10 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 91 |
| DB00245 | CXQ | Benzatropine | 1 |
| DB00458 | IXX | Imipramine | 1 |
| DB00539 | T0R | Toremifene | 1 |
| DB00715 | 8PR | Paroxetine | 1 |
| DB01104 | SRE | Sertraline | 1 |
| DB01242 | CXX | Clomipramine | 1 |
| DB09213 | IBP | Dexibuprofen | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 84 |
| MAN | alpha-D-mannopyranose | 3 |
| 8PR | Paroxetine | 1 |
| CQN | Bepridil | 1 |
| CXQ | benztropine | 1 |
| CXX | 3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | 1 |
| GKZ | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide | 1 |
| GON | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide | 1 |
| IBP | IBUPROFEN | 1 |
| IXX | 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | 1 |
| KHG | (1S,3R,5R,7S)-N-(trans-4-aminocyclohexyl)-3-methyl-5-phenyltricyclo[3.3.1.1~3,7~]decane-1-carboxamide | 1 |
| RTZ | 10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine | 1 |
| SRE | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 1 |
| T0R | Toremifene | 1 |
| YOD | (1R,3S,5S,7S)-N-[(1r,4R)-4-aminocyclohexyl]-3-[(methylsulfanyl)methyl]-5-phenyladamantane-1-carboxamide | 1 |
| YPM | (1s,3R,5S,7s)-N-[(1r,4r)-4-aminocyclohexyl]-3,5-diphenyladamantane-1-carboxamide | 1 |
| YPS | (1R,3S,5R,7R)-N-[(1r,4R)-4-aminocyclohexyl]-3-(ethoxymethyl)-5-phenyladamantane-1-carboxamide | 1 |
| ZQH | [(4R)-4-amino-3,3-dimethylpiperidin-1-yl][(1S,3R,5R,6Z,7S)-3-phenyl-6-(2-phenylethylidene)adamantan-1-yl]methanone | 1 |
| ZTL | (1R,2s,3S,5s,7s)-N-[(1r,4r)-4-(aminomethyl)cyclohexyl]-5-phenyladamantane-2-carboxamide | 1 |